Skip to main content
. 2020 Feb 11;2020(2):CD004863. doi: 10.1002/14651858.CD004863.pub6

3.15. Analysis.

3.15

Comparison 3 Darbepoetin alfa or erythropoietin (erythropoiesis‐stimulating agents ‐ ESAs) versus placebo or no treatment, Outcome 15 Inhibition at 3.5 to 4 years.